Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition

Journal of Pediatric Gastroenterology and Nutrition

Volumn 70, Issue 6, 2020, Pages 727-733

  Turner, Dan ^a   Huang, Ying ^b   Martín De Carpi, Javier ^c   Aloi, Marina ^d   Focht, Gili ^a   Kang, Ben ^e   Zhou, Ying ^b   Sanchez, Cesar ^f   Kappelman, Michael D ^g   Uhlig, Holm H ^h   Pujol Muncunill, Gemma ^c   Ledder, Oren ^a   Lionetti, Paolo ⁱ   Dias, Jorge Amil ^j   Ruemmele, Frank M ^k   Russell, Richard K ^l  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^c HOSPITAL SANT JOAN DE DÉU   (Spain)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e Kyungpook National University   (South Korea)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

^j Universidade do Porto   (Portugal)

^k UNIVERSITÉ PARIS DESCARTES   (France)

^l ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

more..

Author keywords

children; corona virus disease 2019; Crohn disease; inflammatory bowel disease; treatment

Indexed keywords

IMMUNOLOGIC FACTOR;

ADOLESCENT; ADULT; BETACORONAVIRUS; CHILD; COMPLICATION; CONSENSUS; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; HEALTH CARE SURVEY; HUMAN; INFLAMMATORY BOWEL DISEASE; PANDEMIC; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SEVERITY OF ILLNESS INDEX; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; BETACORONAVIRUS; CHILD; CONSENSUS; CORONAVIRUS INFECTIONS; HEALTH CARE SURVEYS; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATORY BOWEL DISEASES; PANDEMICS; PNEUMONIA, VIRAL; SEVERITY OF ILLNESS INDEX;

EID: 85083205278     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000002729     Document Type: Article

References (23)

1. Zhou P, Yang XL, Wang XG,. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-273.
2. Xiao F, Tang M, Zheng X,. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 2020; [Epub ahead of print].
3. Gu J, Han B, Wang J,. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology 2020; [Epub ahead of print].
4. Guan WJ, Ni ZY, Hu Y,. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; DOI: 10.1056/NEJMoa2002032 [Epub ahead of print].
5. Sun D, Li H, Lu XX,. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study. World J Pediatr 2020; DOI: 10.1007/s12519-020-00354-4 [Epub ahead of print].
6. Zimmermann P, Curtis N,. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J 2020; [Epub ahead of print].
7. Dong Y, Mo X, Hu Y,. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020; DOI: 10.1542/peds.2020-0702 [Epub ahead of print].
8. Lu X, Zhang L,. Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children. N Engl J Med 2020; [Epub ahead of print].
9. Mehta P, McAuley DF, Brown M,. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; DOI: 10.1016/S0140-6736(20)30628-0 [Epub ahead of print].
10. Siddiqi HK, Mehra MR,. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant 2020; [Epub ahead of print].
11. Qin C, Zhou L, Hu Z,. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020; DOI: 10.1093/cid/ciaa248 [Epub ahead of print].
12. D'Antiga L,. Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl 2020; DOI: 10.1002/lt.25756 [Epub ahead of print].
13. Cheng KW, Cheng SC, Chen WY,. Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus. Antiviral Res 2015; 115: 9-16.
14. Zhou Y, Hou Y, Shen J,. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov 2020; 6: 14.
15. Russell CD, Millar JE, Baillie JK,. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020; 395: 473-475.
16. Shang LZJ, Hu Y, Du R,. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet 2020; 395: 683-684.
17. Zhou W, Liu Y, Tian D,. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia. Signal Transduct Target Ther 2020; 5: 18.
18. Jin YH, Cai L, Cheng ZS,. for the Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res 2020; 7: 4.
19. Ungaro RC, Sullivan T, Colombel JF,. What should gastroenterologists and patients know about COVID-19? Clin Gastroenterol Hepatol 2020; [Epub ahead of print].
20. Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Preprint server. 2020.
21. Mao R, Liang J, Shen J,. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol 2020; DOI: 10.1016/S2468-1253(20)30076-5 [Epub ahead of print].
22. An P, Ji M, Ren H,. Protection of 318 inflammatory bowel disease patients from the outbreak and rapid spread of COVID-19 infection in Wuhan. China 2020; [Epub ahead of print].
23. Korean Society of Infectious D, Korean Society of Pediatric Infectious D, Korean Society of E, Korean Society for Antimicrobial T, Korean Society for Healthcare-associated Infection C, Prevention, et al. Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020. J Korean Med Sci 2020; 35: e112.